Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionWP Advisors, LLC
Latest Disclosed Ownership3,657 shares
Latest Disclosed Value $ 1,286,794
WP Advisors, LLC reports 0.55% increase in ownership of AMGN / Amgen Inc.

On May 4, 2026 - WP Advisors, LLC filed a 13F-HR form disclosing ownership of 3,657 shares of Amgen Inc. (US:AMGN) valued at $1,286,715 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 3,637 shares of Amgen Inc.. This represents a change in shares of 0.55% during the quarter. The current value of the position is $1,236,871 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F AMGEN COM 031162100 3,657 20 0.55 1,287 8.07 0.3329
2026-01-28 2025-12-31 13F AMGEN COM 031162100 3,637 -35 -0.95 1,190 14.86 0.2965
2025-10-22 2025-09-30 13F AMGEN COM 031162100 3,672 28 0.77 1,036 1.87 0.2634
2025-08-08 2025-06-30 13F AMGEN COM 031162100 3,644 47 1.31 1,017 -9.20 0.2794
2025-05-12 2025-03-31 13F AMGEN COM 031162100 3,597 -39 -1.07 1,121 18.27 0.3732
2025-02-03 2024-12-31 13F AMGEN COM 031162100 3,636 28 0.78 948 -18.50 0.3157
2024-11-07 2024-09-30 13F AMGEN COM 031162100 3,608 -476 -11.66 1,162 -8.93 0.4248
2024-07-30 2024-06-30 13F AMGEN COM 031162100 4,084 -344 -7.77 1,276 1.43 0.4075
2024-05-08 2024-03-31 13F AMGEN COM 031162100 4,428 -26 -0.58 1,259 -1.87 0.4130
2024-01-31 2023-12-31 13F AMGEN COM 031162100 4,454 -187 -4.03 1,283 2.81 0.4749
2023-10-30 2023-09-30 13F AMGEN COM 031162100 4,641 37 0.80 1,247 22.02 0.5157
2023-07-26 2023-06-30 13F AMGEN COM 031162100 4,604 -221 -4.58 1,022 -12.35 0.4090
2023-04-14 2023-03-31 13F AMGEN COM 031162100 4,825 -12 -0.25 1,166 -8.19 0.4811
2023-01-20 2022-12-31 13F AMGEN COM 031162100 4,837 32 0.67 1,270 17.27 0.5680
2022-10-24 2022-09-30 13F Amgen COM 031162100 4,805 36 0.75 1,083 -6.64 0.4904
2022-07-12 2022-06-30 13F Amgen COM 031162100 4,769 37 0.78 1,160 1.40 0.5043
2022-04-25 2022-03-31 13F Amgen COM 031162100 4,732 -78 -1.62 1,144 5.73 0.4711
2022-02-02 2021-12-31 13F Amgen COM 031162100 4,810 38 0.80 1,082 6.60 0.4508
2021-10-20 2021-09-30 13F Amgen COM 031162100 4,772 37 0.78 1,015 -12.05 0.4162
2021-07-22 2021-06-30 13F Amgen COM 031162100 4,735 73 1.57 1,154 -0.52 0.4811
2021-05-06 2021-03-31 13F Amgen COM 031162100 4,662 34 0.73 1,160 9.02 0.5011
2021-01-27 2020-12-31 13F Amgen COM 031162100 4,628 32 0.70 1,064 -8.90 0.5138
2020-10-16 2020-09-30 13F Amgen COM 031162100 4,596 53 1.17 1,168 8.96 0.7039
2020-08-07 2020-06-30 13F Amgen COM 031162100 4,543 30 0.66 1,072 17.16 0.7538
2020-04-29 2020-03-31 13F Amgen COM 031162100 4,513 54 1.21 915 -14.88 0.8888
2020-01-22 2019-12-31 13F Amgen COM 031162100 4,459 76 1.73 1,075 26.77 1.1098
2019-10-22 2019-09-30 13F Amgen COM 031162100 4,383 -22 -0.50 848 4.43 0.9720
2019-07-23 2019-06-30 13F Amgen COM 031162100 4,405 136 3.19 812 -89.99 0.9054
2019-04-15 2019-03-31 13F Amgen COM 031162100 4,269 34 0.80 8,110 884.22 0.8829
2019-01-17 2018-12-31 13F Amgen COM 031162100 4,235 -76 -1.76 824 -7.83 0.8124
2018-10-31 2018-09-30 13F Amgen COM 031162100 4,311 -21 -0.48 894 11.75 0.8322
2018-07-26 2018-06-30 13F Amgen COM 031162100 4,332 31 0.72 800 9.14 0.7548
2018-05-04 2018-03-31 13F Amgen COM 031162100 4,301 -538 -11.12 733 -12.95 0.7914
2018-02-05 2017-12-31 13F Amgen COM 031162100 4,839 -377 -7.23 842 -13.46 0.8151
2017-11-02 2017-09-30 13F Amgen COM 031162100 5,216 -171 -3.17 973 4.85 0.7349
2017-08-08 2017-06-30 13F Amgen COM 031162100 5,387 -264 -4.67 928 0.11 0.6725
2017-04-17 2017-03-31 13F Amgen COM 031162100 5,651 286 5.33 927 18.24 0.5822
2017-02-10 2016-12-31 13F Amgen COM 031162100 5,365 5,365 784 0.5473
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.